...
search icon
coll-img

Collegium Pharmaceutical Inc Share Price

COLL
NSQ
$45.18
-$0.11
(-0.24%)
1D
Industry: Pharmaceuticals Sector: Health Care

Collegium Pharmaceutical Inc Analyst Forecast

Collegium Pharmaceutical Inc Share Price Chart

Collegium Pharmaceutical Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.43B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
27.7853
Volume info-icon
This is the total number of shares traded during the most recent trading day.
127.13K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.65
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$23.23 L
$50.79 H
$45.18

About Collegium Pharmaceutical Inc, Common Stock

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. more

Industry: PharmaceuticalsSector: Health Care

Collegium Pharmaceutical Inc Stock Returns

Time FrameCOLLSectorS&P500
1-Week Return-0.22%1.07%0.74%
1-Month Return-5.28%1.46%1.28%
3-Month Return1.6%3.51%3.6%
6-Month Return20.06%15.29%7.31%
1-Year Return51.05%7.7%11.97%
3-Year Return74.17%21.02%72.07%
5-Year Return79.79%37.81%76.01%
10-Year Return113.42%139.15%258.47%

Collegium Pharmaceutical Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue310.02M276.87M463.93M566.77M631.45M[{"date":"2020-12-31","value":49.1,"profit":true},{"date":"2021-12-31","value":43.85,"profit":true},{"date":"2022-12-31","value":73.47,"profit":true},{"date":"2023-12-31","value":89.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue130.18M126.25M254.44M240.60M254.10M[{"date":"2020-12-31","value":51.16,"profit":true},{"date":"2021-12-31","value":49.62,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.56,"profit":true},{"date":"2024-12-31","value":99.87,"profit":true}]
Gross Profit179.84M150.62M209.49M326.17M377.34M[{"date":"2020-12-31","value":47.66,"profit":true},{"date":"2021-12-31","value":39.92,"profit":true},{"date":"2022-12-31","value":55.52,"profit":true},{"date":"2023-12-31","value":86.44,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin58.01%54.40%45.15%57.55%59.76%[{"date":"2020-12-31","value":97.07,"profit":true},{"date":"2021-12-31","value":91.03,"profit":true},{"date":"2022-12-31","value":75.56,"profit":true},{"date":"2023-12-31","value":96.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses123.60M132.99M176.17M159.21M207.45M[{"date":"2020-12-31","value":59.58,"profit":true},{"date":"2021-12-31","value":64.11,"profit":true},{"date":"2022-12-31","value":84.92,"profit":true},{"date":"2023-12-31","value":76.75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income56.23M17.63M33.32M166.96M169.90M[{"date":"2020-12-31","value":33.1,"profit":true},{"date":"2021-12-31","value":10.38,"profit":true},{"date":"2022-12-31","value":19.61,"profit":true},{"date":"2023-12-31","value":98.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(57.30M)(42.00M)(124.33M)(158.95M)(131.32M)[{"date":"2020-12-31","value":-5730000000,"profit":false},{"date":"2021-12-31","value":-4200400000,"profit":false},{"date":"2022-12-31","value":-12433200000,"profit":false},{"date":"2023-12-31","value":-15895200000,"profit":false},{"date":"2024-12-31","value":-13132500000,"profit":false}]
Pre-Tax Income27.58M(3.37M)(28.85M)75.73M98.57M[{"date":"2020-12-31","value":27.98,"profit":true},{"date":"2021-12-31","value":-3.42,"profit":false},{"date":"2022-12-31","value":-29.27,"profit":false},{"date":"2023-12-31","value":76.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes830.00K(74.89M)(3.85M)27.58M29.38M[{"date":"2020-12-31","value":2.83,"profit":true},{"date":"2021-12-31","value":-254.92,"profit":false},{"date":"2022-12-31","value":-13.09,"profit":false},{"date":"2023-12-31","value":93.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes26.75M71.52M(25.00M)48.16M69.19M[{"date":"2020-12-31","value":37.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.96,"profit":false},{"date":"2023-12-31","value":67.33,"profit":true},{"date":"2024-12-31","value":96.75,"profit":true}]
Income From Continuous Operations26.75M71.52M(25.00M)48.16M69.19M[{"date":"2020-12-31","value":37.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.96,"profit":false},{"date":"2023-12-31","value":67.33,"profit":true},{"date":"2024-12-31","value":96.75,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income26.75M71.52M(25.00M)48.16M69.19M[{"date":"2020-12-31","value":37.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-34.96,"profit":false},{"date":"2023-12-31","value":67.33,"profit":true},{"date":"2024-12-31","value":96.75,"profit":true}]
EPS (Diluted)0.760.390.561.186.45[{"date":"2020-12-31","value":11.78,"profit":true},{"date":"2021-12-31","value":6.05,"profit":true},{"date":"2022-12-31","value":8.68,"profit":true},{"date":"2023-12-31","value":18.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Collegium Pharmaceutical Inc Ratios

Collegium Pharmaceutical Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

COLL
Cash Ratio 0.67
Current Ratio 1.36
Quick Ratio 1.27

Collegium Pharmaceutical Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

COLL
ROA (LTM) 6.75%
ROE (LTM) 22.96%

Collegium Pharmaceutical Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

COLL
Debt Ratio Lower is generally better. Negative is bad. 0.83
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.17

Collegium Pharmaceutical Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

COLL
Trailing PE 27.79
Forward PE 6.16
P/S (TTM) 1.89
P/B 5.27
Price/FCF 18
EV/R 2.61
EV/Ebitda 5.03
PEG NM

FAQs

What is Collegium Pharmaceutical Inc share price today?

Collegium Pharmaceutical Inc (COLL) share price today is $45.18

Can Indians buy Collegium Pharmaceutical Inc shares?

Yes, Indians can buy shares of Collegium Pharmaceutical Inc (COLL) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in COLL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Collegium Pharmaceutical Inc be purchased?

Yes, you can purchase fractional shares of Collegium Pharmaceutical Inc (COLL) via the Vested app. You can start investing in Collegium Pharmaceutical Inc (COLL) with a minimum investment of $1.

How to invest in Collegium Pharmaceutical Inc shares from India?

You can invest in shares of Collegium Pharmaceutical Inc (COLL) via Vested in three simple steps:

  • Click on Sign Up or Invest in COLL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Collegium Pharmaceutical Inc shares
What is Collegium Pharmaceutical Inc 52-week high and low stock price?

The 52-week high price of Collegium Pharmaceutical Inc (COLL) is $50.79. The 52-week low price of Collegium Pharmaceutical Inc (COLL) is $23.23.

What is Collegium Pharmaceutical Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Collegium Pharmaceutical Inc (COLL) is 27.7853

What is Collegium Pharmaceutical Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Collegium Pharmaceutical Inc (COLL) is 5.27

What is Collegium Pharmaceutical Inc dividend yield?

The dividend yield of Collegium Pharmaceutical Inc (COLL) is 0.00%

What is the Market Cap of Collegium Pharmaceutical Inc?

The market capitalization of Collegium Pharmaceutical Inc (COLL) is $1.43B

What is Collegium Pharmaceutical Inc's stock symbol?

The stock symbol (or ticker) of Collegium Pharmaceutical Inc is COLL

How Can Investors Use Collegium Pharmaceutical Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Collegium Pharmaceutical Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Collegium Pharmaceutical Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Collegium Pharmaceutical Inc shares for Indian investors?

When investing in Collegium Pharmaceutical Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Collegium Pharmaceutical Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Collegium Pharmaceutical Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Collegium Pharmaceutical Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Collegium Pharmaceutical Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top